Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu Xu

Showing results (71-80 of 1,555) with videos related to

Pageof 156
Sort By:
Chemical Communications (Cambridge, England)|April 8, 2015
Magnetic controlling of migration of DNA and proteins using one-step modified gold nanoparticlesLu Xu, Lei Feng, Shuli Dong, et al.
World Journal of Surgical Oncology|November 26, 2025
Development and validation of a nomogram model for predicting acute hepatic dysfunction post-intervention in primary hepatocellular carcinoma: a retrospective case-control studyLu Xu, Linan Du, Jianhua Pan, et al.
Arrhythmia & Electrophysiology Review|August 7, 2025
A Fasciculoventricular Accessory Pathway Featuring Functional Decremental Conduction and QRS VariabilityPin Wang, Yanwei Wang, Chenglong Miao, et al.
Canadian Respiratory Journal|March 12, 2024
Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt PathwayLile Wang, Lu Xu, Shuhua Han, et al.
Genome Medicine|June 19, 2024
Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptomeShucheng Si, Hongyan Liu, Lu Xu, et al.
Molecular Cytogenetics|May 18, 2026
Prenatal diagnosis and genetic counseling of a paternally inherited chromosome 5p13.3p13.2 microduplication in a Chinese familyWei Wang, Lin Zhan, Lu Xu, et al.
European Journal of Medical Research|March 3, 2026
Telitacicept alleviates IgA nephropathy by targeting PDHA1 lactylation to inhibit B cell metabolic reprogramming and lactate-mediated renal injuryLu Xu, Jing-Jing Zhang, Wen-Ting Xu
Bioorganic & Medicinal Chemistry|June 27, 2023
Research progress of STAT3-based dual inhibitors for cancer therapyXiaojuan Yang, Lu Xu, Li Yang, et al.
Journal of Environmental Management|June 9, 2023
On the urban resource and environment carrying capacity in China: A sustainable development paradigmLu Xu, Chunxiao Wang, Ning Ba, et al.
Medicine|June 27, 2026
Pregnancy-related adverse events and congenital disorders associated with aspirin: A real-world pharmacovigilance analysis of the FDA adverse event reporting systemZhou Fang, Yanyan Zhang, Lu Xu, et al.
Pageof 156

Showing results (71-80 of 1,555) with videos related to

Sort By:
Pageof 156
Chemical Communications (Cambridge, England)|April 8, 2015
Magnetic controlling of migration of DNA and proteins using one-step modified gold nanoparticlesLu Xu, Lei Feng, Shuli Dong, et al.
World Journal of Surgical Oncology|November 26, 2025
Development and validation of a nomogram model for predicting acute hepatic dysfunction post-intervention in primary hepatocellular carcinoma: a retrospective case-control studyLu Xu, Linan Du, Jianhua Pan, et al.
Arrhythmia & Electrophysiology Review|August 7, 2025
A Fasciculoventricular Accessory Pathway Featuring Functional Decremental Conduction and QRS VariabilityPin Wang, Yanwei Wang, Chenglong Miao, et al.
Canadian Respiratory Journal|March 12, 2024
Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt PathwayLile Wang, Lu Xu, Shuhua Han, et al.
Genome Medicine|June 19, 2024
Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptomeShucheng Si, Hongyan Liu, Lu Xu, et al.
Molecular Cytogenetics|May 18, 2026
Prenatal diagnosis and genetic counseling of a paternally inherited chromosome 5p13.3p13.2 microduplication in a Chinese familyWei Wang, Lin Zhan, Lu Xu, et al.
European Journal of Medical Research|March 3, 2026
Telitacicept alleviates IgA nephropathy by targeting PDHA1 lactylation to inhibit B cell metabolic reprogramming and lactate-mediated renal injuryLu Xu, Jing-Jing Zhang, Wen-Ting Xu
Bioorganic & Medicinal Chemistry|June 27, 2023
Research progress of STAT3-based dual inhibitors for cancer therapyXiaojuan Yang, Lu Xu, Li Yang, et al.
Journal of Environmental Management|June 9, 2023
On the urban resource and environment carrying capacity in China: A sustainable development paradigmLu Xu, Chunxiao Wang, Ning Ba, et al.
Medicine|June 27, 2026
Pregnancy-related adverse events and congenital disorders associated with aspirin: A real-world pharmacovigilance analysis of the FDA adverse event reporting systemZhou Fang, Yanyan Zhang, Lu Xu, et al.
Pageof 156